US Stock MarketDetailed Quotes

ALGS Aligos Therapeutics

Watchlist
  • 8.040
  • +0.020+0.25%
Close Sep 27 16:00 ET
  • 8.040
  • 0.0000.00%
Post 20:02 ET
25.70MMarket Cap-554P/E (TTM)

Aligos Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
-84.59%1.06M
-63.79%986K
11.66%15.53M
-24.20%2.68M
-21.12%3.24M
86.46%6.89M
5.91%2.72M
219.04%13.91M
863.76%3.54M
167.14%4.11M
Operating revenue
-84.59%1.06M
-63.79%986K
11.66%15.53M
-24.20%2.68M
-21.12%3.24M
86.46%6.89M
5.91%2.72M
219.04%13.91M
863.76%3.54M
167.14%4.11M
Cost of revenue
Gross profit
Operating expense
5.56%27.48M
-13.55%23.03M
-7.02%103.66M
9.38%28.68M
-3.23%22.31M
8.06%26.03M
-30.13%26.64M
-15.97%111.49M
-31.57%26.22M
-33.38%23.05M
Selling and administrative expenses
-31.04%6.38M
-21.63%6.67M
15.93%30.62M
-9.80%6.42M
22.42%6.44M
22.04%9.25M
31.84%8.51M
-7.42%26.41M
-26.74%7.12M
-18.69%5.26M
-General and administrative expense
-31.04%6.38M
-21.63%6.67M
15.93%30.62M
-9.80%6.42M
22.42%6.44M
22.04%9.25M
31.84%8.51M
-7.42%26.41M
-26.74%7.12M
-18.69%5.26M
Research and development costs
25.73%21.1M
-9.75%16.37M
-14.15%73.04M
16.53%22.26M
-10.81%15.87M
1.64%16.78M
-42.75%18.14M
-18.32%85.08M
-33.21%19.1M
-36.76%17.79M
Operating profit
-38.00%-26.41M
7.83%-22.05M
9.69%-88.13M
-14.62%-26M
-0.65%-19.07M
6.14%-19.14M
32.73%-23.92M
23.96%-97.58M
40.23%-22.68M
42.70%-18.95M
Net non-operating interest income expense
-66.60%319K
-22.46%580K
-24.21%1.24M
-267.24%-1.47M
115.67%1.01M
350.47%955K
769.77%748K
1,142.42%1.64M
1,447.69%876K
2,230.00%466K
Non-operating interest income
-66.60%319K
-22.46%580K
-24.21%1.24M
-267.24%-1.47M
115.67%1.01M
350.47%955K
769.77%748K
1,142.42%1.64M
1,447.69%876K
2,230.00%466K
Other net income (expense)
20,521.71%31.35M
-5,364.96%-13.37M
129.67%54K
-50.00%152K
379.12%254K
-464.00%-182K
Other non- operating income (expenses)
20,521.71%31.35M
-5,364.96%-13.37M
----
----
129.67%54K
-50.00%152K
379.12%254K
----
----
-464.00%-182K
Income before tax
129.11%5.25M
-52.03%-34.84M
9.44%-86.88M
-27.87%-27.92M
3.49%-18.01M
9.27%-18.03M
35.56%-22.92M
25.16%-95.94M
42.19%-21.84M
43.44%-18.66M
Income tax
-75.03%189K
-38.46%24K
650.00%795K
-161.22%-30K
167.44%29K
1,510.64%757K
-26.42%39K
-25.87%106K
184.48%49K
-134.13%-43K
Net income
126.93%5.06M
-51.88%-34.86M
8.71%-87.68M
-27.44%-27.89M
3.11%-18.04M
5.69%-18.79M
35.55%-22.96M
25.16%-96.05M
41.97%-21.89M
43.78%-18.62M
Net income continuous Operations
126.93%5.06M
-51.88%-34.86M
8.71%-87.68M
-27.44%-27.89M
3.11%-18.04M
5.69%-18.79M
35.55%-22.96M
25.16%-96.05M
41.97%-21.89M
43.78%-18.62M
Minority interest income
Net income attributable to the parent company
126.93%5.06M
-51.88%-34.86M
8.71%-87.68M
-27.44%-27.89M
3.11%-18.04M
5.69%-18.79M
35.55%-22.96M
25.16%-96.05M
41.97%-21.89M
43.78%-18.62M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
126.93%5.06M
-51.88%-34.86M
8.71%-87.68M
-27.44%-27.89M
3.11%-18.04M
5.69%-18.79M
35.55%-22.96M
25.16%-96.05M
41.97%-21.89M
43.78%-18.62M
Basic earnings per share
106.98%0.75
58.49%-5.5
39.56%-34
27.17%-9.2853
6.82%-10.25
8.51%-10.75
36.90%-13.25
30.12%-56.25
42.70%-12.75
43.59%-11
Diluted earnings per share
106.98%0.75
58.49%-5.5
39.56%-34
27.17%-9.2853
6.82%-10.25
8.51%-10.75
36.90%-13.25
30.12%-56.25
42.70%-12.75
43.59%-11
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue -84.59%1.06M-63.79%986K11.66%15.53M-24.20%2.68M-21.12%3.24M86.46%6.89M5.91%2.72M219.04%13.91M863.76%3.54M167.14%4.11M
Operating revenue -84.59%1.06M-63.79%986K11.66%15.53M-24.20%2.68M-21.12%3.24M86.46%6.89M5.91%2.72M219.04%13.91M863.76%3.54M167.14%4.11M
Cost of revenue
Gross profit
Operating expense 5.56%27.48M-13.55%23.03M-7.02%103.66M9.38%28.68M-3.23%22.31M8.06%26.03M-30.13%26.64M-15.97%111.49M-31.57%26.22M-33.38%23.05M
Selling and administrative expenses -31.04%6.38M-21.63%6.67M15.93%30.62M-9.80%6.42M22.42%6.44M22.04%9.25M31.84%8.51M-7.42%26.41M-26.74%7.12M-18.69%5.26M
-General and administrative expense -31.04%6.38M-21.63%6.67M15.93%30.62M-9.80%6.42M22.42%6.44M22.04%9.25M31.84%8.51M-7.42%26.41M-26.74%7.12M-18.69%5.26M
Research and development costs 25.73%21.1M-9.75%16.37M-14.15%73.04M16.53%22.26M-10.81%15.87M1.64%16.78M-42.75%18.14M-18.32%85.08M-33.21%19.1M-36.76%17.79M
Operating profit -38.00%-26.41M7.83%-22.05M9.69%-88.13M-14.62%-26M-0.65%-19.07M6.14%-19.14M32.73%-23.92M23.96%-97.58M40.23%-22.68M42.70%-18.95M
Net non-operating interest income expense -66.60%319K-22.46%580K-24.21%1.24M-267.24%-1.47M115.67%1.01M350.47%955K769.77%748K1,142.42%1.64M1,447.69%876K2,230.00%466K
Non-operating interest income -66.60%319K-22.46%580K-24.21%1.24M-267.24%-1.47M115.67%1.01M350.47%955K769.77%748K1,142.42%1.64M1,447.69%876K2,230.00%466K
Other net income (expense) 20,521.71%31.35M-5,364.96%-13.37M129.67%54K-50.00%152K379.12%254K-464.00%-182K
Other non- operating income (expenses) 20,521.71%31.35M-5,364.96%-13.37M--------129.67%54K-50.00%152K379.12%254K---------464.00%-182K
Income before tax 129.11%5.25M-52.03%-34.84M9.44%-86.88M-27.87%-27.92M3.49%-18.01M9.27%-18.03M35.56%-22.92M25.16%-95.94M42.19%-21.84M43.44%-18.66M
Income tax -75.03%189K-38.46%24K650.00%795K-161.22%-30K167.44%29K1,510.64%757K-26.42%39K-25.87%106K184.48%49K-134.13%-43K
Net income 126.93%5.06M-51.88%-34.86M8.71%-87.68M-27.44%-27.89M3.11%-18.04M5.69%-18.79M35.55%-22.96M25.16%-96.05M41.97%-21.89M43.78%-18.62M
Net income continuous Operations 126.93%5.06M-51.88%-34.86M8.71%-87.68M-27.44%-27.89M3.11%-18.04M5.69%-18.79M35.55%-22.96M25.16%-96.05M41.97%-21.89M43.78%-18.62M
Minority interest income
Net income attributable to the parent company 126.93%5.06M-51.88%-34.86M8.71%-87.68M-27.44%-27.89M3.11%-18.04M5.69%-18.79M35.55%-22.96M25.16%-96.05M41.97%-21.89M43.78%-18.62M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 126.93%5.06M-51.88%-34.86M8.71%-87.68M-27.44%-27.89M3.11%-18.04M5.69%-18.79M35.55%-22.96M25.16%-96.05M41.97%-21.89M43.78%-18.62M
Basic earnings per share 106.98%0.7558.49%-5.539.56%-3427.17%-9.28536.82%-10.258.51%-10.7536.90%-13.2530.12%-56.2542.70%-12.7543.59%-11
Diluted earnings per share 106.98%0.7558.49%-5.539.56%-3427.17%-9.28536.82%-10.258.51%-10.7536.90%-13.2530.12%-56.2542.70%-12.7543.59%-11
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --------------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data